Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 5, 2024

Cenntro Inc.
(Exact Name of Registrant as Specified in Charters)

(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS. Employer Identification No.)

501 Okerson Road, Freehold, New Jersey 07728
(Address of Principal Executive Offices, and Zip Code)

(732) 820-6757
Registrant's Telephone Number, Including Area Code
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Trading Symbol(s)
Name of exchange on which registered
Comon Stock, $0.0001 par value per share
The Nasdaq Capital Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
As previously reported in our Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on April 3, 2024, the board of directors (the “Board”) of Cenntro Inc. (the “Company”) accepted the resignation of Stephen Markscheid as independent director of the Board effective April 3, 2024. Mr. Markscheid’s resignation was not a result of any disagreement with the Company on any matter relating to its operations, policies, or practices, or to any issues regarding its accounting policies or practices.

Mr. Markscheid was an independent director of the Company and served on the compensation, audit and nominating committees of the Board.

Due to the vacancy left by Mr. Markscheid, on June 5, 2025, the nominating committee of the Board did approve and the Board did rectify the vacancy with the appointment Dr. Yi Zeng, an independent director of the Board as a member of the audit committee of the Board, effective April 3, 2024.

Item 9.01.
Financial Statements and Exhibits.
(d) Exhibits

Exhibit No.
Cover Page Interactive Data File (embedded within the Inline XBRL document).

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: June 7, 2024
Cenntro Inc.
By: /s/ Peter Z. Wang
Peter Z. Wang
Chief Executive Officer